Heart failure drug developments and SGLT2 inhibitor updates in 2026

σε πρόσθεσε στο Health

2025-12-19 11:06:11 -

Expanding the role of metabolic management in cardiac recovery The landscape of cardiology is witnessing a profound shift as we move through 2026, with a particular focus on medications that manage metabolic pathways to support the heart muscle. Recent clinical data has shown that certain classes of medications, originally intended for glucose management, are now fundamental in reducing...

0 Σχόλια 0 Μοιράστηκε 12 Views 0 Προεπισκόπηση